NM_004281.4(BAG3):c.838C>T (p.Pro280Ser) AND multiple conditions

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Feb 24, 2020
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001367438.7

Allele description [Variation Report for NM_004281.4(BAG3):c.838C>T (p.Pro280Ser)]

NM_004281.4(BAG3):c.838C>T (p.Pro280Ser)

Gene:

BAG3:BAG cochaperone 3 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

10q26.11

Genomic location:

Preferred name:

NM_004281.4(BAG3):c.838C>T (p.Pro280Ser)

HGVS:

NC_000010.11:g.119672585C>T
NG_016125.1:g.26216C>T
NM_004281.4:c.838C>TMANE SELECT
NP_004272.2:p.Pro280Ser
LRG_742:g.26216C>T
NC_000010.10:g.121432097C>T

Protein change:

P280S

Links:

dbSNP: rs1210697765

NCBI 1000 Genomes Browser:

rs1210697765

Molecular consequence:

NM_004281.4:c.838C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Myofibrillar myopathy 6
Synonyms:: Myofibrillar myopathy, BAG3-related
Identifiers:: MONDO: MONDO:0013061; MedGen: C2751831; Orphanet: 199340; OMIM: 612954

Name:: Dilated cardiomyopathy 1HH (CMD1HH)
Identifiers:: MONDO: MONDO:0013479; MedGen: C3151293; Orphanet: 154; OMIM: 613881

Recent activity

Clear Turn Off Turn On

Homo sapiens methyltransferase 1, tRNA methylguanosine (METTL1), transcript vari...
Homo sapiens methyltransferase 1, tRNA methylguanosine (METTL1), transcript variant 3, mRNA
gi|1675158029|ref|NM_023033.4|

Nucleotide
Mus musculus expressed sequence D19397 (D19397), mRNA
Mus musculus expressed sequence D19397 (D19397), mRNA
gi|23956377|ref|NM_153582.1|

Nucleotide
BACKGROUND - Provisional Peer-Reviewed Toxicity Values for trans-Crotonaldehyde ...
BACKGROUND - Provisional Peer-Reviewed Toxicity Values for trans-Crotonaldehyde (CASRN 123-73-9)
Related DataSets for GEO Profiles (Select 18816729) (1)
GEO DataSets
Autocrine platelet-derived growth factor inhibition effect on malignant gliomas
Autocrine platelet-derived growth factor inhibition effect on malignant gliomas
Accession: GDS1730

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV001563787	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Feb 24, 2020)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV001563787

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Feb 24, 2020)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001563787.4

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with BAG3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with serine at codon 280 of the BAG3 protein (p.Pro280Ser). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and serine.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine